Garcia

Garcia v. Sanofi Pasteur Inc.

Good Law
United States District Court, Eastern District of CaliforniaSeptember 11, 20241:20-cv-00850California1,828 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF CALIFORNIA 10 TERESA GARCIA, No. 1:20-cv-00850-MCE-JDP Plaintiff, v. MEMORANDUM AND ORDER SANOFI PASTEUR INC., et al., Defendants. 16 Plaintiff Teresa Garcia (“Plaintiff”) initiated this personal injury lawsuit against Merck Sharp & Dohme Corp. (“Merck”), the manufacturer and distributer of the Pneumovax® 23 (“Pneumovax 23”) pneumococcal disease vaccine, and Sanofi Pasteur Inc. (“Sanofi”), the manufacturer of the Adacel® (“Adacel”) Tetanus, Diphtheria, Pertussis (“TDaP”) vaccine, (collectively, “Defendants”) for injuries sustained following her inoculation with both vaccines in April 2018. After she initially filed this action in state Court, Merck removed it here and both Defendants filed motions to dismiss, which were granted with leave to amend. ECF Nos. 7, 15, 17. Plaintiff then filed a First Amended Complaint (“FAC”), ECF No. 30, after which Defendants filed a second round of Motions to Dismiss, which were granted as well, with…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.